Education
About Us
Working with TipRanks
Follow Us
Doximity (DOCS)
NYSE:DOCS
DOCS Stock Chart & Stats
$40.63
-$0.33(-0.59%)
At close: 4:00 PM EST
$40.63
-$0.33(-0.59%)
Day’s Range― - ―
52-Week Range$39.50 - $85.21
Previous CloseN/A
Volume296.07K
Average Volume (3M)2.41M
Market Cap
$7.65B
Enterprise Value$7.47B
Total Cash (Recent Filing)$878.37M
Total Debt (Recent Filing)$11.27M
Price to Earnings (P/E)32.4
Beta1.38
Next Earnings
Feb 05, 2026EPS Estimate
0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.45
Shares Outstanding137,373,860
10 Day Avg. Volume2,325,960
30 Day Avg. Volume2,410,304
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)10.01
Price to Sales (P/S)19.01
P/FCF Ratio40.65
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue12.02
Enterprise Value/Gross Profit13.33
Enterprise Value/Ebitda26.76
Forecast
1Y Price Target
$61.91Price Target Upside52.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Advertising Reallocation To Healthcare ProvidersAnalyst notes that tighter rules on direct-to-consumer advertising and slower TV ad demand could drive marketing budgets toward healthcare-provider platforms, positioning Doximity to capture incremental ad dollars.
AI And Product InnovationAnalyst highlights Doximity's AI initiatives, including DoxGPT and recent strategic acquisition, as potential catalysts to boost clinician engagement and unlock new monetization avenues if management lays out execution plans.
Platform Engagement And Competitive MoatAnalyst emphasizes the platform's deep integration into clinicians' daily workflows and trusted content as a durable moat that supports higher engagement, improved monetization, and long-term revenue resilience.
Bears Say
Competition And Market-share RiskAnalyst warns that perceived momentum and public relations gains by OpenEvidence could translate into real market-share pressure and weigh on Doximity's growth outlook and valuation.
Investor Sentiment Driven By Narrow Data PointsAnalyst cautions that investor extrapolation of a single guidance metric into a company-wide deceleration can trigger outsized selling and misprice the stock relative to underlying fundamentals.
Slowing Direct-to-consumer Ad DynamicsAnalyst points to a long-term decline in return on investment for direct-to-consumer TV ads and slower DTC budget growth as a constraint on overall ad market expansion that could limit upside for ad-dependent platforms.
Doximity News
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $39.50 and its highest was $85.21 in the past 12 months.
What is Doximity’s market cap?
Doximity’s market cap is $7.65B.
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is Feb 05, 2026 which is in 9 days.
How were Doximity’s earnings last quarter?
Doximity released its earnings results on Nov 06, 2025. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.379 by $0.071.
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Undervalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is 0.45.
How many shares outstanding does Doximity have?
Doximity has 137,373,860 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Doximity reported an EPS of $0.45 in its last earnings report, beating expectations of $0.379. Following the earnings report the stock price went down -13.247%.
Which hedge fund is a major shareholder of Doximity?
Currently, no hedge funds are holding shares in DOCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Doximity Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$61.91 (52.38% Upside)
$61.91 (52.38% Upside)
Blogger Sentiment
Bullish
DOCS Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 72.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 3.5%
Last 30 Days ▼ 3.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.01%
12-Months-Change
Fundamentals
Return on Equity
24.61%
Trailing 12-Months
Asset Growth
12.39%
Trailing 12-Months
Company Description
Doximity
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
DOCS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Doximity's earnings call highlighted strong financial performance and growth, particularly in revenue and AI adoption. Despite some uncertainties regarding future budgets and increased investment costs, the company's successful integration of Pathway and continued client engagement and expansion indicate a robust position in the market.View all DOCS earnings summariesDOCS Revenue Breakdown
93.00% Subscription
7.00% Other
DOCS Stock 12 Month Forecast
Average Price Target
$61.91
▲(52.38% Upside)
Technical Analysis
Omnicell
―
Evolent Health
―
Teladoc
―
Definitive Healthcare Corp
―
Tempus AI, Inc. Class A
―
Ownership Overview
2.43% Insiders
31.66% Mutual Funds
0.42% Other Institutional Investors
45.96% Public Companies and
Individual Investors